Drug Profile
Leuprolide oral formulation - Arisgen
Alternative Names: LeuprorelinLatest Information Update: 27 Sep 2023
Price :
$50
*
At a glance
- Originator Arisgen
- Class Antineoplastics; Gonadotropins; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 27 Sep 2023 Discontinued - Preclinical for Cancer in Switzerland (PO)
- 28 Jan 2019 No recent reports of development identified for preclinical development in Cancer in Switzerland (PO)